PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
about
CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factorDichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer CellsAntineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cellsProtein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylationCalcium-dependent dephosphorylation of brain mitochondrial calcium/cAMP response element binding protein (CREB)Inhibition of neuronal phenotype by PTEN in PC12 cellsPTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit.Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?New developments in the medical management of prostate cancer.Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.The C2A domain of JFC1 binds to 3'-phosphorylated phosphoinositides and directs plasma membrane association in living cells.Determining PTEN functional status by network component deduced transcription factor activitiesTargeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancerThe pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals.Dasatinib induces autophagic cell death in human ovarian cancer.Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.CREB is a novel nuclear target of PTEN phosphatase.FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasionRole of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells.Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.In LNCaP cells enhanced expression of both androgen receptor and costimulatory protein p300 compensate for antisense oligonucleotide suppression of bcl-2.Programmed cell death and survival pathways in prostate cancer cells.Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks.The use of gene therapy in cancer research and treatment.The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasionDevelopment of Ad-mda7/IL-24-resistant lung cancer cell lines.Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinomaClinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinomaIncidence, mechanism and prognostic value of activated AKT in pancreas cancer.Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression.Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP MiceTissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.PTEN Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERT Pathway in Lung Adenocarcinoma A549 Cells.Cell signalling and radiation survival: the impact of protein phosphatases.Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
P2860
Q24321230-8CC8F262-1BD4-474C-AEEF-A503B9103E57Q26795738-C2DC9C6A-F967-4D1B-B4BD-D2999D5E664BQ28288947-19926F02-1D10-4954-A700-CD6064D417D7Q28474754-55D15BA8-AD82-4195-91F4-07C12542B3C8Q28565987-47A67D82-588A-47BB-A8A6-D80D4A91FA26Q28576729-FA969C9D-C84C-4EED-A61D-9EDFDFABF34BQ30308560-4347D484-FC8B-43EE-AAA6-B4EF72C61E78Q33480331-6758718D-FBB9-4474-876B-393230292EAFQ33566738-0537D096-623D-4AC9-BB54-71E6D61F452FQ33755125-11B6E411-3D5C-403C-9405-50381741C473Q34153990-091FF2D1-2EC3-4C93-83AA-8AFEC307FEDBQ34162672-6109542E-5E70-4C95-AC85-EBB515D8B8E0Q34173253-8F5956DD-A8B8-445A-91B9-C39B8205816DQ34197861-B5B53A9A-AF46-4287-A386-094FD023A657Q34197932-838E5BC5-BF3C-4A7C-9333-2BBDD2D1F618Q34286944-9ECFD9E8-272D-4886-9DD4-B813C725B287Q34289623-7F0C731D-C253-4E79-BE75-5F4197B04CE5Q35019216-75916207-C482-4506-8A84-F35FC5C571D4Q35024427-798E2201-6269-4AD6-91C6-0C15CD9E016CQ35131571-930266F7-2818-45CD-A6A7-D1BED21174B5Q35238068-FF1D8A1A-FC3B-4E11-86D9-72E69E4F7AE7Q35551042-5E074132-3E58-41B6-9411-39417BF70A77Q35588394-592AD69E-2B7B-49BA-AC4B-9C9FE4A2DB7EQ35601956-40BC2E95-1518-4E17-BFCB-048ADC67B76AQ35648549-28E49D3B-AE2E-4C13-8241-FCA990D89B06Q35743146-F23D3F6B-5593-46A3-90EC-7799994EAFCAQ35904008-CDB3EB83-ECAC-45B3-9E2A-0EA406BC0161Q35976355-75CF2686-84B2-44E1-9B19-56718092CE87Q36121693-3FAD8DA2-F5BC-4624-9384-E4FD826121D4Q36235233-48BBDD1B-7D96-4AD3-84DB-62999C169228Q36290399-6244AF02-681B-462F-B731-5AF8A4A62A22Q36358045-9AF364BA-A7F2-41E8-9A97-E2002498A8D7Q36648105-0C0A9A9D-06CF-4F19-BCE2-4A93B5CE2336Q36714276-B36CC81F-BCAD-48D2-B263-EE7797C9B6D9Q37219900-55DAD262-7EBA-494D-81E5-555904B31CFBQ37257253-D06C2DFF-26C9-448B-83B4-D0E32E6A33C1Q37301697-C9453150-F335-4DC9-B1A2-37F9B1EDE0B6Q37378282-88C14C24-4532-47B1-8375-D71E960206E6Q37628726-5DCEDAD2-C15A-42D1-A9B2-7E60195B2D96Q37682212-723CDA30-F547-472A-B6CD-EC850DAE8DB2
P2860
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@en
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@nl
type
label
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@en
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@nl
prefLabel
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@en
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@nl
P2093
P2860
P356
P1476
PTEN induces chemosensitivity ...... ppression of Bcl-2 expression.
@en
P2093
P2860
P304
38830-38836
P356
10.1074/JBC.M103632200
P407
P577
2001-08-08T00:00:00Z